Background {#Sec1}
==========

Stroke is one of the most common acute and severe diseases presenting to an emergency department (ED) \[[@CR1]\]. The early assessment and management of stroke patients should reduce morbidity and mortality \[[@CR1]\]. The use of a stroke screening tool to identify the symptoms and signs of suspected stroke and TIA increases diagnostic accuracy of medical staff in pre-hospital and ED \[[@CR1]\]. The widely recommended stroke scales in the western world include the Recognition of Stroke in the Emergency Room scale (ROSIER), the Face Arm Speech Test (FAST) and the Los Angeles Prehospital Stroke Screen (LAPSS). ROSIER is a seven-item ranging score from −2 to +5 that includes the clinical history (loss of consciousness, convulsive fit) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect). FAST contains three key elements including facial weakness, arm weakness, and speech disturbance. LAPSS consists of four history items, a blood glucose measure, and three examination items designed to detect unilateral motor weakness \[[@CR2]--[@CR5]\]. However, our previous study demonstrated these three stroke scales were not effective for differentiating stroke from stroke mimics in Chinese settings \[[@CR6], [@CR7]\]. The reasons may be related to the difference in factors affecting the incidence of stroke subtypes and stroke mimic in different ethnic populations \[[@CR8]\]. Therefore, it is necessary to develop a stroke scale suitable to a Chinese emergency setting.

The aims of our study were firstly to identify factors that predict stroke, secondly to develop a new stroke scale in our emergency setting, and thirdly to compare the diagnostic value of the new stroke scale with ROSIER, FAST and LAPSS.

Methods {#Sec2}
=======

Study design {#Sec3}
------------

A prospective observational study of patients with suspected stroke was conducted from May 2012 to March 2013. Ethical approval was obtained from the Clinical Research Ethics Committee of the 2nd Affiliated Hospital of Guangzhou Medical University. Written consents were also obtained from all patients or the closest available relatives. Patients were informed that they might withdraw from the study at any time.

Study setting {#Sec4}
-------------

This study was conducted in the emergency department of the second Affiliated Hospital of Guangzhou Medical University (AHGZMU), which serves a population of approximately 1.56 million people in the Hai Zhu district, Guangzhou. It is an academic hospital with 1500 beds affiliated with the Guangzhou Medical University. The ED receives more than 150,000 new patients per annum and serves a local population of approximately 1,550,000 people.

Inclusion and exclusion criteria {#Sec5}
--------------------------------

Suspected stroke patients ≥18 years old presenting to the ED with symptoms or signs within 7 days were recruited. Patients were excluded if they were \<18 years old, had traumatic brain injury, subarachnoid hemorrhage, or unknown diagnoses.

Measurements and data collection {#Sec6}
--------------------------------

Demographic data, clinical manifestations, risk factors, medical history information and the assessment of ROSIER, FAST and LAPSS were collected \[[@CR2], [@CR3]\]. The final diagnosis was made by a specialist stroke physician after assessment and review of clinical symptoms and brain imaging findings (CT or MR). All the patients were divided into stroke or non-stroke groups based on the final diagnosis. Glasgow Coma Scale (GCS) was used to assess the severity of coma (the motor score was applied to the non-affected limb) \[[@CR9]\]. All the patients' scores in this study were assessed by an emergency doctor who has obtained the certification of National Institute of Health Stroke Scale.

Definitions {#Sec7}
-----------

Stroke was defined as a focal or global neurological deficit with symptoms lasting for 24 h or resulting in death before 24 h, which was thought to be due to a vascular cause after investigation \[[@CR3]\]. TIA was defined as clinical syndromes characterized by an acute loss of focal cerebral or monocular function with symptoms lasting less than 24 h and thought to be caused by in adequate blood supply as a result of thrombosis or embolism \[[@CR3]\]. Vertigo is defined as the illusion of movement in space \[[@CR10]\].

Statistical analyses {#Sec8}
--------------------

Categorical variables were compared using Chi-square analysis, whilst continuous variables were compared using independent t-tests. Univariate analysis was initially used on all variables, and results were presented as ORs with 95 % CIs. Variables that were identified as significant from the univariate analysis (*p* \< 0.05) were entered into logistic regression models to identify independent factors for differentiation of stroke from stroke mimics. The backward stepwise regression analyses were used to construct the models. Significant predictive variables generated in the first model were selected for the final model. The receiver operating characteristics (ROC) curve analysis was utilized to determine the optimal cut-off value of GZSS for discriminating between patients with stroke and stroke mimic. Diagnostic performances of the new stroke scale, ROSIER, FAST and LAPSS were also compared using ROC analysis. The sensitivities, specificities, positive and negative predictive values (PPV and NPV), positive and negative likelihood ratios (LR+ and LR-), and diagnostic accuracy were calculated. Statistical significance was set at *p* \< 0.05. All analyses were performed using SPSS v17.0 (SPSS Inc, IL, USA) and Medcalc v9.5 (MedCalc Software, Mariakerke, Belgium).

Results {#Sec9}
=======

Patient characteristics {#Sec10}
-----------------------

Four hundred and sixteen patients were assessed between May 2012 and March 2013. There were 358 (86.1 %) stroke cases, including 247 (69.0 %) ischemic stroke, 107 (29.9 %) intracerebral hemorrhage, 4 (1.1 %) TIA, and 58 (13.9 %) non-stroke cases (Fig. [1](#Fig1){ref-type="fig"}). Compared with non-stroke group, patients with stroke had higher systolic blood pressure (SBP), diastolic blood pressure (DBP) and incidence of several symptoms and signs including asymmetric facial weakness, asymmetric arm weakness, asymmetric leg weakness, speech disturbance, visual field defect, gaze palsy, loss of consciousness or syncope and pathologic reflex (Table [1](#Tab1){ref-type="table"}). However, non-stroke patients had higher incidence of vertigo, nausea and vomiting. The most common stroke mimics were cervical spondylosis, seizure, peripheral vertigo, which together composed 68.9 % of non-stroke cases (Table [2](#Tab2){ref-type="table"}). Among the 61 cases of stroke patients with GCS ≤8, there were 47 patients with intracerebral hemorrhage (77 %) and 14 patients with ischemia stroke (23 %), including 8 cases with total anterior circulation stroke and middle cerebral artery occlusion, 3 cases with partial anterior circulation stroke and stroke past history, 3 cases with posterior circulation stroke located in brain stem (Table [3](#Tab3){ref-type="table"}).Fig. 1Flowchart of stroke patient recruitmentTable 1Baseline demographic characteristics of stroke and non-stroke patients (*n* = 416)VariablesStroke *n* = 358Non-stroke *n* = 58*P*Age69.2 ± 13.870.6 ± 11.40.397Male, *n* (%)210 (58.7)37 (63.8)0.460SBP, mmHg168.8 ± 31.9147.8 ± 27.6\<0.001\*DBP, mmHg91.8 ± 20.780.8 ± 14.3\<0.001\*bpm80.9 ± 18.180.0 ± 13.30.742Medical history, *n* (%) Smoker146 (40.8)20 (34.5)0.339 Hypertension202 (56.4)34 (58.6)0.992 Diabetes58 (16.2)14 (24.1)0.157 Hyperlipidemia40 (11.2)9 (15.5)0.407 Ischemic heart disease36 (10.1)8 (13.8)0.434 Atrial fibrillation28 (7.8)1 (1.7)0.148Symptoms & signs, *n* (%) Asymmetric facial weakness181 (50.6)8 (13.8)\<0.001\* Asymmetric arm weakness217 (60.6)7 (12.1)\<0.001\* Asymmetric leg weakness228 (63.7)9 (15.5)\<0.001\* Speech disturbance195 (54.5)17 (29.3)\<0.001\* Visual field defect68 (19.0)1 (1.7)0.001\* gaze palsy115 (32.1)5 (8.6)\<0.001\* Sensory deficits78 (21.8)8 (13.8)0.163 Loss of consciousness or syncope119 (33.2)10 (17.2)0.015\* Seizure activity21 (5.9)6 (10.3)0.319 Pathologic reflex102 (28.5)8 (13.8)0.019\* Meningeal irritation22 (6.1)0 (0)0.102 Vertigo26 (7.3)19 (32.8)\<0.001\* Headache25 (7.0)3 (5.2)0.816 Nausea59 (16.5)26 (44.8)\<0.001\* Vomiting51 (14.2)23 (39.7)\<0.001\*Score GCS \> 8, *n* (%)297 (83)56 (96.6)0.007\* GCS ≤ 8, *n* (%)61 (17)2 (3.4)0.007\* GCS, median (IQR)15 (12--15)15 (15--15)\<0.001\*\*Statistically significant difference was observed between two groupsTable 2Diagnoses of stroke and non-stroke patients (*n* = 416)Diagnoses*N* (%)Stroke classification358 (100.0) Total anterior circulation stroke41 (11.5) Partial anterior circulation stroke97 (27.1) Lacunar stroke88 (24.6) Posterior circulation stroke21 (5.7) Intracerebral Hemorrhage107 (29.9) Transient Ischemic attack4 (1.1)Non-stroke58 (100.0) cervical spondylosis28 (48.3) Seizure6 (10.3) Peripheral vertigo6 (10.3) Parkinson's disease2 (3.5) Vasovagal syncope2 (3.5) Other^a^14 (24.1)^a^Other diagnoses: hyponatremia and hypokalemia (*n* = 1), hypoglycemic coma (*n* = 1), alcoholic cirrhosis (*n* = 1), overdose of clozapine (*n* = 1), chronic obstructive pulmonary disease (*n* = 1), cerebral arteriosclerosis (*n* = 1), Hashimoto's encephalopathy (*n* = 1), vascular headache (*n* = 1), medulla oblongata and cervical vertebrae (C1-C2) focus (*n* = 1), scrub typhus (*n* = 1), central nervous system infection (*n* = 1), periodic paralysis (*n* = 1), facial neuritis (*n* = 1), left middle cerebral artery (M1) following stenting (*n* = 1)Table 3The subtype of stroke patients with GCS ≤ 8Diagnoses*N* (%)Intracerebral Hemorrhage47 (77.0)Ischemia stroke14 (23.0)Total anterior circulation stroke8Partial anterior circulation stroke3Posterior circulation stroke3Total61 (100.0)

Development of the new stroke scale {#Sec11}
-----------------------------------

Logistic regression analysis of clinical symptoms and signs for stroke and non-stroke patients are shown in Table [4](#Tab4){ref-type="table"}. GCS ≤8 was recognized as the highest prevalence, following by visual field defect, asymmetric arm weakness, asymmetric leg weakness, SBP ≥145 mmHg, DBP ≥95 mmHg, speech disturbance and vertigo. As shown in Table [5](#Tab5){ref-type="table"}, the items of the new stroke scale with total score from −1 to 8.5 included vertigo (−1), GCS ≤ 8 (+2), Asymmetric facial weakness (+1), asymmetric arm weakness (+1), asymmetric leg weakness (+1), speech disturbance (+0.5), visual field defect (+1), SBP ≥145 mmHg (+1), DBP ≥95 mmHg (+1). We developed the new scale based on *P* value of Multiple Logistic regression and odds ratio (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}).Table 4Factors associated with stroke using logistic regression analysisVariablesUnivariate regressionMultivariate regression*N* (%)OR (95 % CI)*P*OR (95 % CI)*P*Female169 (40.6)1Male247 (59.4)0.81 (0.45--1.43)0.461Age0.99 (0.97--1.01)0.457GCS \> 8353 (84.9)1GCS ≤ 863 (15.1)5.75 (1.37--24.20)0.017\*5.70 (1.26--25.80)0.024\*Seizure activity NO389 (93.5)1 YES27 (6.5)0.54 (0.21--0.54)0.205Vertigo NO371 (89.1)1 YES45 (10.8)0.16 (0.08--0.32)\<0.001\*0.34 (0.15--0.74)0.007\*Asymmetric facial weakness NO227 (54.6)1 YES189 (45.4)6.39 (2.95--13.87)\<0.001\*2.44 (0.97--6.11)0.057Asymmetric arm weakness NO192 (46.2)1 YES224 (53.8)11.21 (4.95--25.41)\<0.001\*3.39 (1.04--11.08)0.043\*Asymmetric leg weakness NO179 (43.0)1 YES237 (57.0)9.55 (4.54--20.07)\<0.001\*2.77 (0.88--8.70)0.081Speech disturbance NO204 (49.0)1 YES212 (51.0)2.89 (1.58--5.27)0.001\*1.29 (0.58--2.84)0.524Visual field defect NO347 (83.4)1 YES69 (16.6)13.37 (1.82--98.23)0.011\*3.93 (0.48--32.30)0.202Gaze palsy NO296 (71.2)1 YES120 (28.8)5.02 (1.95--12.89)0.001\*0.75 (0.19--3.08)0.693Pathologic reflex NO306 (73.6)1 YES110 (26.4)2.49 (1.14--5.44)0.022\*0.73 (0.28--1.91)0.516SBP ≥ 145 mmHg NO111 (26.7)1 YES305 (73.3)3.99 (2.25--7.07)\<0.001\*2.55 (1.25--5.24)0.011\*DBP ≥ 95 mmHg NO270 (64.9)1 YES146 (35.1)4.62 (2.04--10.48)\<0.001\*2.29 (0.87--6.03)0.093\*Statistically significant (*p* \<0.05)Table 5Clinical signs and symptoms for development of the new stroke scaleVariablesScore*β*OR (95 % CI)*P* valueVertigo−1−1.090.34 (0.15--0.74)0.007\*GCS ≤ 821.745.70 (1.26--25.80)0.024\*Asymmetric facial weakness10.892.44 (0.97--6.11)0.057Asymmetric arm weakness11.223.39 (1.04--11.08)0.043\*Asymmetric leg weakness11.022.77 (0.88--8.70)0.081Speech disturbance0.50.261.29 (0.58--2.84)0.524Visual field defect11.373.93 (0.48--32.30)0.202SBP ≥ 145 mmHg10.942.55 (1.25--5.24)0.011\*DBP ≥ 95 mmHg10.832.29 (0.87--6.03)0.093\**P* \< 0.05Stroke is likely if total scores are \>1.5

Diagnostic performances of ROSIER, FAST, LAPSS and GZSS {#Sec12}
-------------------------------------------------------

The nine-item scoring system for GZSS was constructed. Comparison of GZSS to ROSIER, FAST and LAPSS was undertaken using ROC analysis (Fig. [2](#Fig2){ref-type="fig"}). The area under curve (AUC) of GZSS was 0.871 (95 % CI 83.5--90.2), whilst the AUC of ROSIER was 0.772 (95% CI 72.8--81.1), LAPSS was 0.722 (95 % CI 67.6--74.6) and FAST was 0.699 (95 % CI 65.2--74.3). By pairwise comparison of the AUC of the four scales (adjusted α = 0.008), the comparison was statistically significant (*p* \< 0.001). Among the four scales, the diagnostic value of GZSS was the best (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Receiver operating characteristic ROC curves of GZSS, ROSIER, FAST and LAPSS in differentiation of stroke and non-stroke patients

The optimal cut-off score of GZSS was determined to be a total score of 1.5. At this cut-off score, the corresponding sensitivity and specificity were 83.2 % (95 % CI 79.0--87.0) and 74.1 % (95 % CI 61.0--84.7). The sensitivity and specificity of ROSIER scale were 77.7 % (95 % CI 73.0--81.9) and 70.7 % (95 % CI 57.3--81.9) when the optimal cut-off score was 0. The sensitivity and specificity of FAST scale were 76.0 % (95 % CI 71.2--80.3) and 63.8 % (95 % CI 50.1--76.0) when the optimal cut-off score was 0. The sensitivity and specificity of LAPSS scale were 56.4 % (95 % CI 51.1--61.6) and 87.9 % (95 % CI 76.7--95.0) when the optimal cut-off score was 0. The sensitivity of GZSS was the best and was significantly different from the sensitivities of ROSIER scale (*p* = 0.031), FAST scale (*p* = 0.004) and LAPSS scale (*p* \< 0.001) (Table [6](#Tab6){ref-type="table"}).Table 6Diagnostic performance of ROSIER, FAST, LAPSS and GZSSScaleOptimal cut-offSensitivity (95 % CI)*P*Specificity (95 % CI)*P*PLR (95 % CI)NLR (95 % CI)PPV (95 % CI)NPV (95 % CI)Diagnostic accuracy (%)ROSIER077.7 (73.0--81.9)0.03170.7 (57.3--81.9)0.7542.65 (1.8--4.0)0.32 (0.2--0.4)94.2 (90.9--96.6)33.9 (25.5--43.1)76.68FAST076.0 (71.2--80.3)0.00463.8 (50.1--76.0)0.2102.1 (1.5--3.0)0.38 (0.3--0.5)92.8 (89.2--95.5)30.1 (22.1--39.0)74.28LAPSS056.4 (51.1--61.6)\<0.00187.9 (76.7--95.0)0.0084.68 (2.3--9.4)0.50 (0.4--0.6)96.7 (93.2--98.6)24.6 (18.9--31.1)60.82GZSS1.583.2 (79.0--87.0)Reference74.1 (61.0--84.7)Reference3.22 (2.1--5.0)0.23 (0.2--0.3)95.2 (92.2--97.3)41.7 (32.1--51.9)81.97*ROSIER* Recognition of Stroke in the Emergency Room scale, *FAST* Face Arm Speech Test, *LAPSS* Los Angeles Pre-Hospital Stroke Screen, *GZSS* Guangzhou Stroke Scale, *PLR* positive likelihood ratio, *NLR* negative likelihood ratio, *PPV* positive predictive value, *NPV* negative predictive value

Discussion {#Sec13}
==========

This was the first study to develop a new stroke scale in China. In recent years, the incidence of stroke is still rising year by year around the world and its high morbidity can cause serious social and family burden \[[@CR11]--[@CR14]\]. Early recognition and timely treatment of patients with acute stroke by emergency physicians are critical and improve the prognosis of stroke patients \[[@CR15]--[@CR22]\]. Stroke screening scales were recommended by guidelines in pre-hospital and emergency room for rapid triage of suspected patients \[[@CR1], [@CR3], [@CR23]--[@CR25]\].

In this study, we found that there were significant differences in the distribution of stroke subtypes between the patients in our study and the Western patients in the studies using other scales. There was a higher proportion of intracerebral haemorrhage in our study compared with the other Western studies \[[@CR26]--[@CR29]\]. Also, there were less ischaemic stroke (69 versus 76 %) and TIA (1.1 versus 10 %), but more haemorrhagic stroke (29.9 versus 14 %) in our study than in the ROSIER study \[[@CR2]\]. These differences in subtype patterns are postulated to be due to differences in genetic, clinical, environmental and lifestyle factors \[[@CR8], [@CR30], [@CR31]\]. There were also differences in the proportion of stroke mimics between this study and the other Western studies, Seizures (10.3 %) and syncope (17.2 %) in Guangzhou were less common than in the UK (47 %) \[[@CR2]\]. Another UK study found that primary headache disorders and seizures comprised up to 27 % of stroke mimics \[[@CR32]\], whilst in Greece \[[@CR33]\] the principal stroke mimics were aphasic disturbances (27.3 %) and dizziness or fainting (27.3 %).

We analyzed different clinical features of stroke in our ED and thus developed a new stroke recognition instrument (score range: −1 to 8.5), which consisted of nine items including vertigo (−1), GCS ≤ 8 (+2), facial paralysis (+1), asymmetric upper limb paralysis (+1), asymmetric lower limb paralysis (+1), speech disorders (+0.5), visual field defect (+1), SBP ≥145 mmHg (+1), DBP ≥95 mmHg (+1). The new stroke scale showed good discriminative value in our ED.

In GZSS, five recognition items were the same as in ROSIER scale, FAST score and LAPSS. These items with different odds ratios were included in the new stroke scale, such as asymmetric facial weakness (OR: 6.39), asymmetric arm weakness (OR: 11.21), asymmetric leg weakness (OR: 9.55), speech disturbance (OR: 2.89), visual field defect (OR: 13.37). We assigned the corresponding score to each item of the new scale based on the logistic regression coefficients.

There were some new items added in GZSS based on the analysis. In our previous study, we found that the level of consciousness of patients may affect the diagnostic value of the stroke screening scales \[[@CR2], [@CR6], [@CR7]\]. Therefore, we assessed the diagnostic value of GCS in patients with suspected stroke. We found that GCS equal or less than 8 points (OR: 5.75) was associated with the diagnosis of stroke. Stroke patients often have disturbance of consciousness and are unable to cooperate in medical examinations. It would be difficult for coma patients to carry out some of the physical examinations, such as paralysis and speech disorders. In this case, most of the stroke screening scales developed in western countries, such as FAST and LAPSS, cannot be applied to stroke patients with loss of consciousness. Also, if stroke patients present with loss of consciousness and do not have paralysis and speech disorders, the total score of ROSIER scale is equal to or less than 0 and thus means stroke is not likely to occur. This would easily lead to false negative. Therefore, we included GCS in GZSS to compensate the deficiency of the other stroke scales.

Vertigo was another new item in GZSS. Our study suggested vertigo occurred more often in Chinese non-stroke population than Western population. In the western population, the proportion of stroke and non-stroke patients with vertigo were similar (6 and 5 %, respectively) \[[@CR2]\]. However, 58.6 % of patients had cervical spondylosis and peripheral vertigo in this study. By logistic regression analysis, the regression coefficient βof vertigo was negative, which suggested that vertigo was a differential symptom between stroke and non-stroke patients.

In addition, our new scale included SBP and DBP. We used ROC analysis to determine the optimal cut-off values of SBP (≥145 mmHg) and DBP (≥95 mmHg). By logistic regression analysis, we found that the OR of SBP and DBP were2.55 and 2.29, respectively. When acute stroke occurs, SBP and DBP are higher than usual. Blood pressure of more than 80 % of patients increased within 24 to 48 h after the onset of cerebral ischemic, and declined gradually in a few days or several weeks. One of the reasons might be due to the regulation disorder of cerebral blood flow in ischemic penumbra \[[@CR34], [@CR35]\]. Patients with hemorrhagic stroke experienced increased intracranial pressure, and thus the blood pressure would increase to maintain the normal cerebral blood flow. In this study, the blood pressure was higher in patients with stroke than non-stroke (*p* \< 0.01). Also, 392 patients (94.2 %) including 337 stroke patients (81.0 %) and 55 non-stroke patients (13.2 %) presented to ED within 24 h after symptom onset. Only 5.8 % of patients presented over 24 h after symptom onset. This indicated that the vast majority of patients with suspected stroke in our study were in acute period of cerebral apoplexy. Therefore, blood pressure also played a significant role in the diagnosis of patients with suspected stroke in the emergency department.

A comparison of the new stroke scale with the other three scales (ROSIER scale, FAST scale and LAPSS scale) was conducted in our ED. We found that the new scale had better sensitivity than the other scales. The AUC of GZSS was the largest (AUC = 0.871). At the optimal cut-off score of 1.5, GZSS gave high sensitivity and comparable specificity. It may be more effective to use GZSS to screen Chinese patients with suspected stroke in ED.

Limitations {#Sec14}
-----------

There were several limitations in this study. First, this study was a single-center study. Our results may not be generalizable to other parts of China, let alone elsewhere in the world. Multicenter studies with larger sample sizes are needed to explore the effectiveness of this new stroke scale. Second, using GCS in GZSS may not be appropriate in all circumstances. A patient who has had a stroke may be aphasic and hemiplegic. They may be fully conscious but only scored E4V1M6 giving them a GCS of 11/15, which is clearly misleading. It may be necessary to break down the GCS into the component parts (i.e. E4V1M6 instead of GCS 9) to get much more information. Third, it would have been stronger to have separate derivation and validation datasets rather than a single dataset. Therefore, further studies with larger sample sizes are required to validate the effectiveness of GZSS and improve its weakness.

Conclusion {#Sec15}
==========

GZSS had better sensitivity than the existing stroke scales in Chinese patients with suspected stroke. Further studies are required to validate its usefulness in the initial differentiation of acute stroke from stroke mimics.
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